Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcelo F. Di Carli, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Marcelo Di Carli and Ron Blankstein.
Marcelo Di Carli
Connection Strength
22.602
Ron Blankstein
  1. Coronary Plaque Volume and Stenosis: Important Determinants of Myocardial Ischemia. J Am Coll Cardiol. 2018 02 06; 71(5):510-512.
    View in: PubMed
    Score: 0.747
  2. Quantifying Plaque Burden and Morphology Using Coronary Computed Tomography Angiography to Predict Coronary Physiology: Helpful…But Is It Sufficient? Circ Cardiovasc Imaging. 2015 Oct; 8(10):e004058.
    View in: PubMed
    Score: 0.634
  3. Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis. J Am Coll Cardiol. 2014 Aug 12; 64(6):631.
    View in: PubMed
    Score: 0.586
  4. Low yield of routine preoperative coronary computed tomography angiography in patients evaluated for liver transplantation. Circulation. 2014 Oct 14; 130(16):1337-9.
    View in: PubMed
    Score: 0.586
  5. Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis. J Am Coll Cardiol. 2014 Jun 17; 63(23):2590.
    View in: PubMed
    Score: 0.573
  6. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
    View in: PubMed
    Score: 0.554
  7. Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol. 2010 Apr; 7(4):226-36.
    View in: PubMed
    Score: 0.431
  8. Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: the Mass General Brigham YOUNG-MI Registry. Eur J Prev Cardiol. 2022 03 11; 29(2):352-359.
    View in: PubMed
    Score: 0.248
  9. Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study. JAMA Cardiol. 2022 01 01; 7(1):93-99.
    View in: PubMed
    Score: 0.245
  10. Impact of coronary artery calcium testing on patient management. J Cardiovasc Comput Tomogr. 2021 Dec 17.
    View in: PubMed
    Score: 0.244
  11. Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer. J Nucl Cardiol. 2021 Nov 24.
    View in: PubMed
    Score: 0.243
  12. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J. 2021 Sep 07.
    View in: PubMed
    Score: 0.239
  13. Multimodality imaging to distinguish between benign and malignant cardiac masses. J Nucl Cardiol. 2021 Sep 02.
    View in: PubMed
    Score: 0.239
  14. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging. 2022 02; 15(2):312-321.
    View in: PubMed
    Score: 0.238
  15. Natural language processing for the assessment of cardiovascular disease comorbidities: The cardio-Canary comorbidity project. Clin Cardiol. 2021 Sep; 44(9):1296-1304.
    View in: PubMed
    Score: 0.238
  16. Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry. JAMA Cardiol. 2021 08 01; 6(8):880-888.
    View in: PubMed
    Score: 0.238
  17. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. Eur J Prev Cardiol. 2021 07 23; 28(8):e12-e14.
    View in: PubMed
    Score: 0.237
  18. Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. J Am Heart Assoc. 2021 07 06; 10(13):e018555.
    View in: PubMed
    Score: 0.236
  19. Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma: The YOUNG-MI Registry. JACC CardioOncol. 2021 Jun; 3(2):319-321.
    View in: PubMed
    Score: 0.236
  20. Role of Cardiac CT in Pre-Procedure Planning for Transcatheter Mitral Valve Replacement. JACC Cardiovasc Imaging. 2021 08; 14(8):1571-1580.
    View in: PubMed
    Score: 0.233
  21. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 11; 14(11):2212-2220.
    View in: PubMed
    Score: 0.232
  22. Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2021 Jan 04.
    View in: PubMed
    Score: 0.228
  23. Use of cardiac CT amidst the COVID-19 pandemic and beyond: North American perspective. J Cardiovasc Comput Tomogr. 2021 Jan-Feb; 15(1):16-26.
    View in: PubMed
    Score: 0.226
  24. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry. Eur Heart J. 2020 11 07; 41(42):4127-4137.
    View in: PubMed
    Score: 0.226
  25. What is Multimodality Cardiovascular Imaging and How Can It Be Delivered? Heart. 2020 Oct 27.
    View in: PubMed
    Score: 0.225
  26. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry. Clin Cardiol. 2020 Nov; 43(11):1209-1215.
    View in: PubMed
    Score: 0.223
  27. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 05 10; 62(5):716-722.
    View in: PubMed
    Score: 0.223
  28. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2021 12; 28(6):2976-2987.
    View in: PubMed
    Score: 0.221
  29. Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry. JAMA Netw Open. 2020 07 01; 3(7):e209649.
    View in: PubMed
    Score: 0.220
  30. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.220
  31. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. Eur J Prev Cardiol. 2020 Jun 23.
    View in: PubMed
    Score: 0.220
  32. Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2020 06 09; 75(22):2804-2815.
    View in: PubMed
    Score: 0.220
  33. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022 Feb; 29(1):37-42.
    View in: PubMed
    Score: 0.219
  34. Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults. J Am Coll Cardiol. 2020 03 10; 75(9):1003-1013.
    View in: PubMed
    Score: 0.216
  35. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.212
  36. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry. Am J Med. 2020 05; 133(5):605-612.e1.
    View in: PubMed
    Score: 0.211
  37. Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry. Diabetes Care. 2020 08; 43(8):1843-1850.
    View in: PubMed
    Score: 0.209
  38. Stress Myocardial Blood Flow Ratio by Dynamic CT Perfusion Identifies Hemodynamically Significant CAD. JACC Cardiovasc Imaging. 2020 04; 13(4):966-976.
    View in: PubMed
    Score: 0.209
  39. Response by Divakaran et al to Letter Regarding Article, "Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis: An Imaging-Histologic Correlation Study in Patients Undergoing Cardiac Transplantation". Circ Cardiovasc Imaging. 2019 08; 12(8):e009622.
    View in: PubMed
    Score: 0.207
  40. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study. J Nucl Cardiol. 2021 06; 28(3):1089-1099.
    View in: PubMed
    Score: 0.205
  41. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.205
  42. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2019 05 21; 73(19):2439-2450.
    View in: PubMed
    Score: 0.204
  43. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.203
  44. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019 01 08; 8(1):e007829.
    View in: PubMed
    Score: 0.199
  45. Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction. Circulation. 2018 12 11; 138(24):2855-2857.
    View in: PubMed
    Score: 0.198
  46. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2019 02; 26(1):188-199.
    View in: PubMed
    Score: 0.196
  47. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
    View in: PubMed
    Score: 0.193
  48. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
    View in: PubMed
    Score: 0.193
  49. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2018 06 05; 71(22):2540-2551.
    View in: PubMed
    Score: 0.188
  50. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.188
  51. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
    View in: PubMed
    Score: 0.186
  52. Causes of Troponin Elevation and Associated Mortality in Young Patients. Am J Med. 2018 03; 131(3):284-292.e1.
    View in: PubMed
    Score: 0.186
  53. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.185
  54. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
    View in: PubMed
    Score: 0.184
  55. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol. 2018 01 23; 71(3):292-302.
    View in: PubMed
    Score: 0.184
  56. Use of Cardiac Computerized Tomography to Predict Neo-Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement. J Am Heart Assoc. 2017 11 04; 6(11).
    View in: PubMed
    Score: 0.183
  57. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
    View in: PubMed
    Score: 0.183
  58. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017 10; 24(5):1741-1758.
    View in: PubMed
    Score: 0.182
  59. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
    View in: PubMed
    Score: 0.181
  60. Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry. Clin Cardiol. 2017 Nov; 40(11):955-961.
    View in: PubMed
    Score: 0.181
  61. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.177
  62. Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry. Cardiovasc Diabetol. 2017 01 25; 16(1):14.
    View in: PubMed
    Score: 0.174
  63. Role of Imaging in Evaluating Infiltrative Heart Disease. Curr Treat Options Cardiovasc Med. 2017 Jan; 19(1):3.
    View in: PubMed
    Score: 0.173
  64. Transthoracic Echocardiography to Assess Aortic Regurgitation after TAVR: A Comparison with Periprocedural Transesophageal Echocardiography. Cardiology. 2017; 137(1):1-8.
    View in: PubMed
    Score: 0.172
  65. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
    View in: PubMed
    Score: 0.171
  66. The value of noninvasive computed tomography derived fractional flow reserve in our current approach to the evaluation of coronary artery stenosis. Curr Opin Cardiol. 2016 11; 31(6):970-976.
    View in: PubMed
    Score: 0.171
  67. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
    View in: PubMed
    Score: 0.169
  68. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging. 2016 Sep; 9(9):e005001.
    View in: PubMed
    Score: 0.169
  69. European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry. Circulation. 2016 Jul 19; 134(3):201-11.
    View in: PubMed
    Score: 0.167
  70. Clinical Outcomes After Evaluation of Stable Chest Pain by Coronary Computed Tomographic Angiography Versus Usual Care: A Meta-Analysis. Circ Cardiovasc Imaging. 2016 Apr; 9(4):e004419.
    View in: PubMed
    Score: 0.164
  71. Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA. Eur Heart J Cardiovasc Imaging. 2017 Feb; 18(2):224-235.
    View in: PubMed
    Score: 0.162
  72. 3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2016 Jan-Feb; 10(1):28-36.
    View in: PubMed
    Score: 0.161
  73. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
    View in: PubMed
    Score: 0.159
  74. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46.
    View in: PubMed
    Score: 0.154
  75. Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
    View in: PubMed
    Score: 0.153
  76. Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging. J Nucl Med. 2015 Apr; 56(4):592-9.
    View in: PubMed
    Score: 0.153
  77. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):900-9.
    View in: PubMed
    Score: 0.152
  78. Incremental prognostic value of kidney function decline over coronary artery disease for cardiovascular event prediction after coronary computed tomography. Kidney Int. 2015 Jul; 88(1):152-9.
    View in: PubMed
    Score: 0.151
  79. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
    View in: PubMed
    Score: 0.150
  80. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
    View in: PubMed
    Score: 0.149
  81. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol. Circ Cardiovasc Imaging. 2014 Jul; 7(4):629-38.
    View in: PubMed
    Score: 0.145
  82. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
    View in: PubMed
    Score: 0.144
  83. Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography. Curr Cardiol Rep. 2014 May; 16(5):483.
    View in: PubMed
    Score: 0.144
  84. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
    View in: PubMed
    Score: 0.144
  85. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014 Mar; 7(2):282-91.
    View in: PubMed
    Score: 0.142
  86. Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274.
    View in: PubMed
    Score: 0.141
  87. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
    View in: PubMed
    Score: 0.141
  88. Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease. Atherosclerosis. 2014 Mar; 233(1):190-5.
    View in: PubMed
    Score: 0.141
  89. Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74.
    View in: PubMed
    Score: 0.140
  90. Cardiometabolic risk is associated with atherosclerotic burden and prognosis: results from the partners coronary computed tomography angiography registry. Diabetes Care. 2014 Feb; 37(2):555-64.
    View in: PubMed
    Score: 0.138
  91. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013 Apr; 20(2):310-2.
    View in: PubMed
    Score: 0.133
  92. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol. 2013 May 21; 61(20):2098-106.
    View in: PubMed
    Score: 0.133
  93. Meta-analysis of coronary CT angiography in the emergency department. Eur Heart J Cardiovasc Imaging. 2013 Jun; 14(6):607.
    View in: PubMed
    Score: 0.133
  94. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials. J Am Coll Cardiol. 2013 Feb 26; 61(8):880-92.
    View in: PubMed
    Score: 0.132
  95. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012 Oct; 5(10):1025-34.
    View in: PubMed
    Score: 0.129
  96. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012 Oct 09; 126(15):1858-68.
    View in: PubMed
    Score: 0.128
  97. Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging. J Nucl Cardiol. 2012 Aug; 19(4):814-7.
    View in: PubMed
    Score: 0.127
  98. Correlative imaging of spontaneous coronary artery dissection. J Nucl Cardiol. 2012 Jun; 19(3):625-9.
    View in: PubMed
    Score: 0.126
  99. Comparison of cardiac computed tomography examination appropriateness under the 2010 revised versus the 2006 original Appropriate Use Criteria. J Cardiovasc Comput Tomogr. 2012 Mar-Apr; 6(2):99-107.
    View in: PubMed
    Score: 0.123
  100. Comparison of the Diamond-Forrester method and Duke Clinical Score to predict obstructive coronary artery disease by computed tomographic angiography. Am J Cardiol. 2012 Apr 01; 109(7):998-1004.
    View in: PubMed
    Score: 0.122
  101. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011 Oct 18; 58(17):1807-16.
    View in: PubMed
    Score: 0.121
  102. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011 Nov 15; 124(20):2215-24.
    View in: PubMed
    Score: 0.121
  103. Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32.
    View in: PubMed
    Score: 0.108
  104. Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes. J Am Heart Assoc. 2022 01 04; 11(1):e022010.
    View in: PubMed
    Score: 0.061
  105. Cardiac Sarcoidosis: When and How to Treat Inflammation. Card Fail Rev. 2021 Mar; 7:e17.
    View in: PubMed
    Score: 0.061
  106. A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing. J Am Coll Cardiol. 2021 09 28; 78(13):1385-1389.
    View in: PubMed
    Score: 0.060
  107. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022 Apr; 29(2):440-446.
    View in: PubMed
    Score: 0.056
  108. Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 09 15; 76(11):1345-1357.
    View in: PubMed
    Score: 0.055
  109. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2021 10; 28(5):1988-1997.
    View in: PubMed
    Score: 0.053
  110. Incidental Coronary Artery Calcification in Cancer Imaging. JACC CardioOncol. 2019 Sep; 1(1):135-137.
    View in: PubMed
    Score: 0.052
  111. Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. Radiol Cardiothorac Imaging. 2019 Jun; 1(2):e180018.
    View in: PubMed
    Score: 0.051
  112. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
    View in: PubMed
    Score: 0.050
  113. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
    View in: PubMed
    Score: 0.048
  114. Evolving, innovating, and revolutionary changes in cardiovascular imaging: We've only just begun! J Nucl Cardiol. 2018 06; 25(3):758-768.
    View in: PubMed
    Score: 0.047
  115. Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association. Circ Cardiovasc Imaging. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.046
  116. Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017 08; 58(8):1341-1353.
    View in: PubMed
    Score: 0.045
  117. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? J Nucl Cardiol. 2017 10; 24(5):1610-1618.
    View in: PubMed
    Score: 0.045
  118. Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality. J Cardiovasc Magn Reson. 2014 Jun 19; 16:43.
    View in: PubMed
    Score: 0.036
  119. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54.
    View in: PubMed
    Score: 0.034
  120. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation. 2013 Aug 06; 128(6):605-14.
    View in: PubMed
    Score: 0.034
  121. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012 Oct; 19(5):970-8.
    View in: PubMed
    Score: 0.031
  122. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging. 2011 Aug; 4(8):850-61.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.